Drug Patent Expirations for the week of September 9, 16, and 23, 2012

Drug Patent Expirations for the week of September 9, 2012

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
LOTEMAX	Bausch And Lomb	loteprednol etabonate	4,996,335*PED	Sep 9, 2012
ALREX	Bausch And Lomb	loteprednol etabonate	4,996,335*PED	Sep 9, 2012
ZYLET	Bausch And Lomb	loteprednol etabonate; tobramycin	4,996,335*PED	Sep 9, 2012

Drug Patent Expirations for the week of September 16, 2012

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
EMEND	Merck And Co Inc	fosaprepitant dimeglumine	7,214,692	Sep 18, 2012
EMEND	Merck	aprepitant	7,214,692	Sep 18, 2012
LUMIGAN	Allergan	bimatoprost	6,403,649	Sep 21, 2012
DIOVAN	Novartis	valsartan	5,399,578*PED	Sep 21, 2012
EXFORGE HCT	Novartis	amlodipine besylate; hydrochlorothiazide; valsartan	5,399,578*PED	Sep 21, 2012
LATISSE	Allergan	bimatoprost	6,403,649	Sep 21, 2012
DIOVAN HCT	Novartis	hydrochlorothiazide; valsartan	5,399,578*PED	Sep 21, 2012
EXFORGE	Novartis	amlodipine besylate; valsartan	5,399,578*PED	Sep 21, 2012

Drug Patent Expirations for the week of September 23, 2012

Tradename	Applicant	Generic Name	Patent Number	Patent Expiration
SYMBICORT	Astrazeneca	budesonide; formoterol fumarate dihydrate	6,641,800	Sep 23, 2012
TIKOSYN	Pfizer	dofetilide	4,959,366	Sep 25, 2012
DETROL	Pharmacia And Upjohn	tolterodine tartrate	5,382,600*PED	Sep 25, 2012
DETROL LA	Pharmacia And Upjohn	tolterodine tartrate	5,382,600*PED	Sep 25, 2012
NIMBEX PRESERVATIVE FREE	Abbvie	cisatracurium besylate	5,453,510	Sep 26, 2012
NIMBEX	Abbvie	cisatracurium besylate	5,453,510	Sep 26, 2012
VIAGRA	Pfizer Ireland	sildenafil citrate	5,250,534*PED	Sep 27, 2012
REVATIO	Pfizer	sildenafil citrate	5,250,534*PED	Sep 27, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.